Literature DB >> 561654

Transferrin promotion of 67Ga and 59Fe uptake by cultured mouse myeloma cells.

A W Harris, R G Sephton.   

Abstract

Radiotracer 67Ga-citrate is used as a tumor-seeking agent in clinical imaging investigations although fundamental reasons for its high uptake in certain malignant lesions remain unexplained. The mechanism by which 67Ga becomes concentrated in tumor cells has been investigated by comparing 67Ga and 59Fe uptake by cultured mouse myeloma cells with particular reference to uptake stimulation by transferrin. Concentrations of human transferrin down to 2 microgram/ml greatly stimulated cellular uptake of both tracers, whereas bovine transferrin proved relatively inactive. The rates of stimulated uptake of both tracers were similar as was their high degree of retention by cells, but their quantitative dependencies on transferrin concentration showed characteristic differences. Pretreatment of human transferrin with saturating amounts of nonradioactive Fe3+ canceled its ability to promote 59Fe uptake, but it had little effect on its promotion of 67Ga uptake. Further increase in the amount of added Fe3+ did cause a progressive depression of 67Ga uptake, but this effect probably relates to the iron distribution in the whole-cell culture system including the fetal calf serum component of cell growth medium. The results suggest that 67Ga and 59Fe reveal different aspects of the interaction of transferrin with cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 561654

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Effects of different transferrin forms on transferrin receptor expression, iron uptake, and cellular proliferation of human leukemic HL60 cells. Mechanisms responsible for the specific cytotoxicity of transferrin-gallium.

Authors:  C R Chitambar; P A Seligman
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

2.  Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase.

Authors:  Christopher R Chitambar; Mona M Al-Gizawiy; Hisham S Alhajala; Kimberly R Pechman; Janine P Wereley; Robert Wujek; Paul A Clark; John S Kuo; William E Antholine; Kathleen M Schmainda
Journal:  Mol Cancer Ther       Date:  2018-03-28       Impact factor: 6.261

3.  In vitro and in vivo effects of ferric citrate on 67Ga-citrate uptake by DS sarcoma tumors.

Authors:  L J Anghileri; P Thouvenot; F Brunotte; C Marchal; J Robert
Journal:  Eur J Nucl Med       Date:  1982

Review 4.  Current role of gallium scanning in the management of lymphoma.

Authors:  A F McLaughlin; M A Magee; R Greenough; K C Allman; A E Southee; S R Meikle; B F Hutton; D E Joshua; G J Bautovich; J G Morris
Journal:  Eur J Nucl Med       Date:  1990

Review 5.  Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.

Authors:  Einat Even-Sapir; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-18       Impact factor: 9.236

Review 6.  Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.

Authors:  Christopher R Chitambar; William E Antholine
Journal:  Antioxid Redox Signal       Date:  2012-10-03       Impact factor: 8.401

Review 7.  Medical applications and toxicities of gallium compounds.

Authors:  Christopher R Chitambar
Journal:  Int J Environ Res Public Health       Date:  2010-05-10       Impact factor: 3.390

8.  67Ga-transferrin and 67Ga-lactoferrin binding to tumor cells: specific versus nonspecific glycoprotein-cell interaction.

Authors:  S Vallabhajosula; S J Goldsmith; H Lipszyc; A P Chahinian; T Ohnuma
Journal:  Eur J Nucl Med       Date:  1983

9.  In vitro binding of 67Ga to isolated rat liver cells.

Authors:  T Suzuki; Y Okada; H Kohno; Y Ohkubo; S Kojima; A Kubodera
Journal:  Eur J Nucl Med       Date:  1985

10.  A preliminary investigation of 67Ga citrate distribution in hyperferraemic patients.

Authors:  F W Smith; P P Dendy; T Pocklington; A A Dawson; M A Foster; J R Mallard
Journal:  Eur J Nucl Med       Date:  1980-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.